Esdaile JM - Search Results

1

Development of Cardiovascular Quality Indicators for Rheumatoid Arthritis: Results from an International Expert Panel Using a Novel Online Process.

Barber CE, Marshall DA, Alvarez N, Mancini GB, Lacaille D, Keeling S, Aviña-Zubieta JA, Khodyakov D, Barnabe C, Faris P, Smith A, Noormohamed R, Hazlewood G, Martin LO, Esdaile JM; Quality Indicator International Panel. Barber CE, et al. Among authors: esdaile jm. J Rheumatol. 2015 Sep;42(9):1548-55. doi: 10.3899/jrheum.141603. Epub 2015 Jul 15. J Rheumatol. 2015. PMID: 26178275 Free PMC article.

2

Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise.

Bellamy N, Buchanan WW, Esdaile JM, Fam AG, Kean WF, Thompson JM, Wells GA, Campbell J. Bellamy N, et al. Among authors: esdaile jm. J Rheumatol. 1991 Nov;18(11):1716-22. J Rheumatol. 1991. PMID: 1787494

3

The relationship of socioeconomic status to subsequent health status in systemic lupus erythematosus.

Esdaile JM, Sampalis JS, Lacaille D, Danoff D. Esdaile JM, et al. Arthritis Rheum. 1988 Mar;31(3):423-7. doi: 10.1002/art.1780310315. Arthritis Rheum. 1988. PMID: 3358803

4

An experiment in reducing interobserver variability of the examination for joint tenderness.

Klinkhoff AV, Bellamy N, Bombardier C, Carette S, Chalmers A, Esdaile JM, Goldsmith C, Tugwell P, Smythe HA, Buchanan WW. Klinkhoff AV, et al. Among authors: esdaile jm. J Rheumatol. 1988 Mar;15(3):492-4. J Rheumatol. 1988. PMID: 3379626

5

The impact of disease activity, treatment and disease severity on short-term costs of systemic lupus erythematosus.

Lacaille D, Clarke AE, Bloch DA, Danoff D, Esdaile JM. Lacaille D, et al. Among authors: esdaile jm. J Rheumatol. 1994 Mar;21(3):448-53. J Rheumatol. 1994. PMID: 8006887

6

Absence of an association of rheumatoid arthritis and diffuse idiopathic skeletal hyperostosis: a case-control study.

Mata S, Wolfe F, Joseph L, Esdaile JM. Mata S, et al. Among authors: esdaile jm. J Rheumatol. 1995 Nov;22(11):2062-4. J Rheumatol. 1995. PMID: 8596145

7

Discontinuation of antimalarial drugs in systemic lupus erythematosus.

Wang C, Fortin PR, Li Y, Panaritis T, Gans M, Esdaile JM. Wang C, et al. Among authors: esdaile jm. J Rheumatol. 1999 Apr;26(4):808-15. J Rheumatol. 1999. PMID: 10229401

8

Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.

Tsakonas E, Fitzgerald AA, Fitzcharles MA, Cividino A, Thorne JC, M'Seffar A, Joseph L, Bombardier C, Esdaile JM. Tsakonas E, et al. Among authors: esdaile jm. J Rheumatol. 2000 Mar;27(3):623-9. J Rheumatol. 2000. PMID: 10743799 Clinical Trial.

9

Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review.

Qushmaq KA, Chalmers A, Esdaile JM. Qushmaq KA, et al. Among authors: esdaile jm. J Rheumatol. 2000 Dec;27(12):2855-9. J Rheumatol. 2000. PMID: 11128676 Review.

10

Survey of antimalarial use in lupus pregnancy and lactation.

Al-Herz A, Schulzer M, Esdaile JM. Al-Herz A, et al. Among authors: esdaile jm. J Rheumatol. 2002 Apr;29(4):700-6. J Rheumatol. 2002. PMID: 11950010

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters